Your browser doesn't support javascript.
loading
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa.
Kocher, Thomas; March, Oliver Patrick; Bischof, Johannes; Liemberger, Bernadette; Hainzl, Stefan; Klausegger, Alfred; Hoog, Anna; Strunk, Dirk; Bauer, Johann Wolfgang; Koller, Ulrich.
Afiliação
  • Kocher T; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • March OP; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Bischof J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Liemberger B; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hainzl S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Klausegger A; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hoog A; Cell Therapy Institute, SCI-TReCS, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Strunk D; Cell Therapy Institute, SCI-TReCS, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Bauer JW; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical Univer
  • Koller U; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address: u.koller@salk.at.
J Invest Dermatol ; 140(10): 1985-1993.e5, 2020 10.
Article em En | MEDLINE | ID: mdl-32142798
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Distrófica / Colágeno Tipo VII / Sistemas CRISPR-Cas / Edição de Genes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Distrófica / Colágeno Tipo VII / Sistemas CRISPR-Cas / Edição de Genes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article